Answers are grounded in this paper and cite their sources.
New chromogenic tripeptide substrates have been used for the determination of kallikreins and urokinase. The conditions have been optimized. It is possible to determine prekallikrein in plasma after activation with Cephotest. No significant loss in activity caused by plasma kallikrein inhibitors is observed at the dilutions used.
No takes yet. Share an insight, caveat, or question.
Claeson et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: